<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="/oai-pmh.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-09-22T00:41:16Z</responseDate>
  <request identifier="oai:www.ideals.illinois.edu:2142/83711" metadataPrefix="etdms" verb="GetRecord">https://www.ideals.illinois.edu/oai-pmh</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:www.ideals.illinois.edu:2142/83711</identifier>
        <datestamp>2023-07-11</datestamp>
        <setSpec>col_2142_5131</setSpec>
        <setSpec>col_2142_14781</setSpec>
        <setSpec>com_2142_5130</setSpec>
        <setSpec>com_2142_687</setSpec>
        <setSpec>com_2142_397</setSpec>
      </header>
      <metadata>
        <thesis xmlns="http://www.ndltd.org/standards/metadata/etdms/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.ndltd.org/standards/metadata/etdms/1.1/ http://www.ndltd.org/standards/metadata/etdms/1.1/etdms11.xsd http://purl.org/dc/elements/1.1/ http://www.ndltd.org/standards/metadata/etdms/1.1/etdmsdc.xsd">
          <dc:contributor>Nakamura, Manabu T.</dc:contributor>
          <dc:creator>Strakova, Jana</dc:creator>
          <dc:date>2015-09-25T21:10:09Z</dc:date>
          <dc:date>2015-09-25T21:10:09Z</dc:date>
          <dc:date>10000-01-01</dc:date>
          <dc:date>2008</dc:date>
          <dc:date>2008</dc:date>
          <dc:description>In mouse liver homogenates, 1000 mumol/L D,L-CBHcy did not inhibit methionine synthase, CBS and cystathionase activities but 5 mumol/L D,L-CBHcy completely inhibited BHMT activity indicating, that D,L-CBHcy was a specific inhibitor of BHMT. To address whether BHMT inhibition caused hyperhomocysteinemia, mice were injected with 1mg of D,L-CBHcy. This reduced BHMT activity (87%) and elevated total plasma Hcy (tHcy, 2.7-fold) for 8 hours. Repeated intraperitoneal injections of D,L-CBHcy (6 doses) additionally reduced the liver  S-adenosylmethionine-to-S-adenosylhomocysteine ratio (65%). To assess whether BHMT inhibition affected liver and plasma amino acids, rats were fed 5mg D,L-CBHcy (9 doses). Plasma methionine and serine decreased (23 and 17%, respectively), while histidine, Hcy and glycine increased (35, 311 and 24% respectively). There were no changes in liver methionine and Hcy, but liver taurine, serine, and glutamate decreased (74, 50 and 46%, respectively). Increased plasma betaine (1465%) confirmed that BHMT was functionally inhibited  in vivo. Interestingly, liver CBS activity and protein levels decreased (56 and 26%, respectively). To assess whether BHMT inhibition affected glutathione levels and/or caused fatty liver, rats were fed either an adequate (4.5g/kg methionine, 3.7g/kg cystine); cystine-devoid (4.5g/kg methionine, 0g/kg cystine) or a methionine-deficient diet (1.5g/kg methionine, 3.7g/kg cystine) alone or in combination with L-CBHcy for 3, 7 or 14 days. L-CBHcy treatment reduced liver glutathione in rats fed the adequate and cysteine-devoid diets. All animals fed the methionine-deficient diet with L-CBHcy developed fatty liver. L-CBHcy treatment decreased liver CBS activity (15--74%) and the effect was exacerbated with time. We conclude that BHMT activity is required for normal levels of plasma Hcy and methionine, liver SAM and glutathione, and CBS activity.</dc:description>
          <dc:description>Made available in DSpace on 2015-09-25T21:10:09Z (GMT). No. of bitstreams: 2
license.txt: 4848 bytes, checksum: 96035ab3f5e1c23cc7138a224ce498bd (MD5)
3314907.pdf: 1539890 bytes, checksum: aa0e6a889670aeb87b9859f78ab381b9 (MD5)
  Previous issue date: 2008</dc:description>
          <dc:description>Embargo set by: Seth Robbins for item 84992
Lift date: Forever
Reason: Restricted to the U of I community idenfinitely during batch ingest of legacy ETDs</dc:description>
          <dc:description>Restricted to the U of I community idenfinitely during batch ingest of legacy ETDs</dc:description>
          <dc:description>U of I Only</dc:description>
          <dc:description>107 p.</dc:description>
          <dc:description>Thesis (Ph.D.)--University of Illinois at Urbana-Champaign, 2008.</dc:description>
          <dc:identifier>http://hdl.handle.net/2142/83711</dc:identifier>
          <dc:identifier>(MiAaPQ)AAI3314907</dc:identifier>
          <dc:language>eng</dc:language>
          <dc:subject>Chemistry, Biochemistry</dc:subject>
          <dc:title>Role of Betaine-Homocysteine S-Methyltransferase in Homocysteine Methylation</dc:title>
          <dc:type>text</dc:type>
          <degree>
            <department>Food Science and Human Nutrition</department>
            <discipline>Food Science and Human Nutrition</discipline>
            <grantor>University of Illinois at Urbana-Champaign</grantor>
            <level>Dissertation</level>
            <name>Ph.D.</name>
          </degree>
        </thesis>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
